Simultaneous Adrenalectomy During Radical Nephrectomy for Renal Cell Carcinoma Will Not Cure Patients With Adrenal Metastasis

Urology

Volumn 73, Issue 2, 2009, Pages 333-336

  von Knobloch, Rolf ^a   Schrader, Andres J ^b   Walthers, Eduard M ^b   Hofmann, Rainer ^b  

^a FRANZISKUS HOSPITAL   (Germany)

^b Fachbereich Medizin der Universitat Marburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; INTERLEUKIN 2;

ADRENAL METASTASIS; ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHRECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 58649120063     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.09.037     Document Type: Article

References (24)

1. Leibovich B.C., Blute M.L., Cheville J.C., et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171 (2004) 1066-1070
2. Marszalek M., Ponholzer A., Brossner C., et al. Elective open nephron-sparing surgery for renal masses: single-center experience with 129 consecutive patients. Urology 64 (2004) 38-42
3. Steinbach F., Stöckle M., Müller S.C., et al. Conservative surgery of renal cell tumors in 140 patients: 21 years of experience. J Urol 148 (1992) 24-29
4. van Poppel H., Bamelis B., Oyen R., et al. Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol 160 (1998) 674-678
5. von Knobloch R., Seseke F., Riedmiller H., et al. Radical nephrectomy for renal cell carcinoma: is adrenalectomy necessary?. Eur Urol 36 (1999) 303-308
6. Robey E.L., and Schellhammer P.F. The adrenal gland and renal cell carcinoma: is ipsilateral adrenalectomy a necessary component of radical nephrectomy?. J Urol 135 (1986) 453-455
7. Robson C.J., Churchill B.M., and Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 101 (1969) 297-301
8. Siemer S., Lehmann J., Kamradt J., et al. Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol 171 (2004) 2155-2159
9. Sandock D.S., Seftel A.D., and Resnick M.I. Adrenal metastases from renal cell carcinoma: role of ipsilateral adrenalectomy and definition of stage. Urology 49 (1997) 28-31
10. Sagalowsky A.I., Kadesky K.T., Ewalt D.M., et al. Factors influencing adrenal metastasis in renal cell carcinoma. J Urol 151 (1994) 1181-1184
11. Paul R., Mordhorst J., Leyh H., et al. Incidence and outcome of patients with adrenal metastases of renal cell cancer. Urology 57 (2001) 878-882
12. Paul R., Mordhorst J., Busch R., et al. Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm. J Urol 166 (2001) 59-62
13. Kozak W., Höltl W., Pummer K., et al. Adrenalectomy-still a must in radical renal surgery?. Br J Urol 77 (1996) 27-31
14. Kuczyk M., Wegener G., and Jonas U. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. Eur Urol 48 (2005) 252-257
15. Kuczyk M., Münch T., Machtens S., et al. The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int 89 (2002) 517-522
16. Kletscher B.A., Qian J., Bostwick D.G., et al. Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma. J Urol 155 (1996) 1844-1846
17. Itano N.B., Blute M.L., Spotts B., et al. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 164 (2000) 322-325
18. von Knobloch R., Hegele A., Kälble T., et al. Management of contralateral adrenal metastasis from renal cell carcinoma: possibility of inferior vena cava tumour thrombus. Scand J Urol Nephrol 34 (2000) 109-113
19. Terrone C., Gontero P., Volpe A., et al. Proposal of an improved prognostic classification for pT3 renal cell carcinoma. J Urol 180 (2008) 72-78
20. Ficarra V., Novara G., Iafrate M., et al. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome. Eur Urol 51 (2007) 722-729
21. Fujita T., Iwamura M., Yanagisawa N., et al. Prognostic impact of perirenal fat or adrenal gland involvement in patients with pT3b renal cell carcinoma. Urology 69 (2007) 839-842
22. Rini B.I., and Campbell S.C. The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy. J Urol 177 (2007) 1978-1984
23. Wood C.G. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res 13 (2007) 697s-702s
24. Ito K., Nakazawa H., Marumo K., et al. Risk factors for ipsilateral adrenal involvement in renal cell carcinoma. Urology 72 (2008) 354-358